Cohort (CHRT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Mar, 2026Leadership and experience
Executive team has decades of defence industry experience, including roles at major defence firms and the UK MOD.
Leadership continuity since foundation, with key executives serving since inception.
Strategic strengths and investment case
Proven business model with a focus on attractive growth markets and niche sectors.
Active acquisition strategy and strong financial position support R&D and capacity investment.
Consistent dividend growth since IPO and visibility of earnings into the mid-2030s.
Business segments and capabilities
Communications and Intelligence segment includes tactical/naval communications, C4I, satellite terminals, cyber security, and EW support.
Sensors and Effectors segment covers EO surveillance, fire control, counter-UAS, sonar, and underwater situational awareness.
Latest events from Cohort
- Record revenue and order book, strong global demand, and robust outlook drive confidence.CHRT
Investor Update3 Feb 2026 - Record results, robust order book, and strong demand support a positive growth outlook.CHRT
H2 20243 Feb 2026 - Acquisition brings new tech, global reach, and strong financial upside in defense markets.CHRT
M&A Announcement13 Jan 2026 - Record revenue, strong order book, and global demand drive positive outlook and margin growth.CHRT
Investor Update12 Jan 2026 - Record revenue, profit, and order book set strong foundation for continued growth.CHRT
H1 202511 Jan 2026 - Revenue up 9% to £128.8m, strong order book, and positive outlook for H2.CHRT
H1 202611 Dec 2025 - Record revenue, profit, and order book with strong outlook driven by global defense demand.CHRT
H2 202516 Nov 2025 - Record revenue and profit growth, strong order book, and higher dividend signal robust outlook.CHRT
H2 2025 Pre-Recorded16 Nov 2025 - Record order book and strong growth position Cohort for continued expansion in defence markets.CHRT
Trading Update6 Jun 2025